Atosiban harness hepatocellular carcinoma progression in human organoid model
RNA-seq (gene expression) · human · 18 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Hepatocellular carcinomaThis series is part of our curated briefing on it.
- Samples
- 18 samples: 6 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE266229_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1106421 and SRA study SRP504900. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 18 samples.
How we read this: 6 replicated groups read from 18 sample titles; they account for 18 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8242669 group1,Vehicle1_1 group1,Vehicle1
- GSM8242670 group1,Vehicle1_2 group1,Vehicle1
- GSM8242671 group1,Vehicle1_3 group1,Vehicle1
- GSM8242672 group2,Vehicle2_1 group2,Vehicle2
- GSM8242673 group2,Vehicle2_2 group2,Vehicle2
- GSM8242674 group2,Vehicle2_3 group2,Vehicle2
- GSM8242675 group3,Vehicle3_1 group3,Vehicle3
- GSM8242676 group3,Vehicle3_2 group3,Vehicle3
- GSM8242677 group3,Vehicle3_3 group3,Vehicle3
- GSM8242678 group1,Atosiban1_1 group1,Atosiban1
- GSM8242679 group1,Atosiban1_2 group1,Atosiban1
- GSM8242680 group1,Atosiban1_3 group1,Atosiban1
- GSM8242681 group2,Atosiban2_1 group2,Atosiban2
- GSM8242682 group2,Atosiban2_2 group2,Atosiban2
- GSM8242683 group2,Atosiban2_3 group2,Atosiban2
- GSM8242684 group3,Atosiban3_1 group3,Atosiban3
- GSM8242685 group3,Atosiban3_2 group3,Atosiban3
- GSM8242686 group3,Atosiban3_3 group3,Atosiban3
- GSE105130 Comprehensive analysis of Transcriptome Profiles in Hepatocellular Carcinoma patients 52 samples same disease briefing · shares hepatocellular
- GSE140228 Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma 41 samples same disease briefing · shares hepatocellular
- GSE14520 Gene expression data of human hepatocellular carcinoma (HCC) 488 samples same disease briefing · shares hepatocellular
- GSE10186 Integrative Transcriptome Analysis Reveals Common Molecular Subtypes of Human Hepatocellular Carcinoma 118 samples same disease briefing · shares hepatocellular
- GSE10143 Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma 387 samples same disease briefing · shares hepatocellular
- GSE107170 Molecular Signature of Hepatitis D Virus-Associated Hepatocellular Carcinoma 307 samples same disease briefing · shares hepatocellular
- GSE109211 Molecular predictors of prevention of recurrence in hepatocellular carcinoma with sorafenib as adjuvant treatment in the phase 3 STORM trial 140 samples same disease briefing · shares hepatocellular
- GSE114564 Identification of novel serum biomarkers in early-stage HCC patients. 118 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.